In many parts of the world, there is an increasing discomfort with middlemen in the healthcare industry (Pearl, 2024). They are characterized as greedy, profit seekers and vilified characters that put money before health and proliferate the markets with fake medicines, putting public health in danger (Kaprove R and M.D 2014, Rowland D 2021, Edema […]
This is the story of how the World Health Organisation (WHO) came to partner with Interpol and the pharmaceutical industry to fight a war against fake drugs. This partnership took the form of a taskforce, the International Medical Products Anti-Counterfeit Taskforce (IMPACT), which contributed greatly to how counterfeit drugs became understood as a threat to […]
Introduction I’m walking through Mwenge, one of Dar es Salaam’s central business districts. I’ve been spending time here with Hassan, a petty cosmetics trader, who carries his goods in a suitcase as he makes his daily tour of the market. We’ve been walking a while and Hassan suggests that we stop by at his favourite […]
It’s a Ramadhan morning in the port city of Mombasa, early April 2023. I’m standing behind an audience of about 100 people who have turned up to a makeshift stage on the edge of the neighbourhood of Old Town. A performance of Lisemwalo Lipo: A play about vaccine rumours is in full swing.
Why should the figure of the middleman matter for scholars of global health? The short answer is: they are impossible to avoid. The long answer is as follows: Throughout the twenty-first century, claims have circulated that the global pharmaceutical supply chain is awash with fakes, and these claims sparked our curiosity. For nearly a decade, […]
